A Phase 1 Dose Escalation Study of GC4419 in Combination With Chemoradiation for Squamous Cell Cancer of the Head & Neck

Clinical trial NCT01921426 · COMPLETED

Trial details

NCT number: NCT01921426
Sponsor: Galera Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of the Oral Cavity Squamous Cell Carcinoma of the Oropharynx

Start date: 2013-08-01
Primary completion: 2015-07-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.